Literature DB >> 20003686

Is the spinal cord motoneuron exclusively a target in ALS? Comparison between astroglial reactivity in a rat model of familial ALS and in human sporadic ALS cases.

Janina Rafalowska1, Dorota Dziewulska, Roman Gadamski, Hanna Chrzanowska, Malgorzata Modrzewska-Lewczuk, Pawel Grieb.   

Abstract

OBJECTIVE: Motoneurons are the focus of most investigations of amyotrophic lateral sclerosis (ALS), while the astrocyte reaction is regarded as a phenomenon secondary to neuron degeneration. Since astroglial reactivity differed in different studies of human and animal ALS models and often varied from case to case, we examined and compared astrocyte reactivity within the anterior horns of the spinal cord in a transgenic rat model of familial ALS and in human sporadic ALS (sALS) cases.
METHODS: Routine histological staining and immunohistochemical reactions to cytoskeletal proteins [neurofilaments, glial fibrillary acidic protein (GFAP), vimentin and tau] and proliferative markers (proliferating cell nuclear antigen and Ki-67).
RESULTS: In human sALS cases and in rats at the early pre-symptomatic and symptomatic stages of the disease, the astroglial reaction was very weak, although there was visible evidence of the morphological manifestations of motoneuron degeneration. Poor immunoreactivity to the GFAP and vimentin antigens and increased expression of tau protein were observed in astrocytes, particularly in the rat model. The astrocyte reaction was evident during a short ‘transient’ phase of the disease in animals, between the asymptomatic and paretic stages. Proliferating cell nuclear antigen immunoreactivity in glial and neuronal nuclei was observed only in animal material.
CONCLUSIONS: Abnormalities in astrocyte cytoskeletal proteins are characteristic features for ALS, both in acquired and congenital forms of the disease. The cytoskeletal aberrations may lead to astroglial dysfunction and disturbances in glutamate uptake that may in turn increase the degeneration of motoneurons.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20003686     DOI: 10.1179/174313209X414542

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

Review 1.  CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.

Authors:  Kathryn J Jones; Amy E Lovett-Racke; Chandler L Walker; Virginia M Sanders
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-07       Impact factor: 4.147

2.  Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice.

Authors:  Nichole A Mesnard; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2011-12-01       Impact factor: 3.215

3.  SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.

Authors:  Nichole A Mesnard-Hoaglin; Junping Xin; Melissa M Haulcomb; Richard J Batka; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2014-06-06       Impact factor: 7.217

Review 4.  ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.

Authors:  Elizabeth B Moloney; Fred de Winter; Joost Verhaagen
Journal:  Front Neurosci       Date:  2014-08-14       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.